Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US
The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...
money.rediff1d
Glenmark Recalls ADHD Medication in US: USFDA
Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine ...
Glenmark recalls 1.5 million bottles of ADHD medication in US: USFDA
Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention ...
Glenmark recalls 15 lakh bottles of ADHD medication in U.S.: USFDA
Glenmark Pharmaceuticals recalls 14.76 lakh bottles of Atomoxetine Capsules in the US due to impurity concerns.
Daily21h
Glenmark US arm recalls 15 lakh bottles of ADHD medication in US
Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh ...
newsbytesapp.com1d
Glenmark recalls 15L bottles of ADHD medicines in the US
Glenmark Pharmaceuticals, a global pharmaceutical giant, is recalling nearly 15 lakh bottles of Atomoxetine capsules from the ...
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...
The Financial Express1d
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States
ADHD is a neurodevelopmental disorder that affects a person's ability to focus, control impulses, and regulate their activity ...
The Tribune1d
Glenmark recalls 15 lakh bottles of attention deficit hyperactivity disorder medication in US
Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based drug maker, is recalling around 14.76 lakh bottles of Atomoxetine Capsules in multiple strengths The Tribune, now published from ...